organization · The Oxfendazole Development Group
Global health and developmentOther
| Coefficient Giving | $1,600,000 | 91% | 1 |
| ACX Grants | $150,000 | 9% | 1 |
| Date ↓ | Funder | Via | Amount | Cause | Source | Purpose |
|---|---|---|---|---|---|---|
| Jun 2022 | Coefficient Giving | $1,600,000 | Global health and development | coefficient_giving | Oxfendazole Toxicity Tests | |
| Dec 2021 | ACX Grants | $150,000 | Other | acx_grants | Development of oxfendazole, a next-generation antiparasitic drug for deworming. — ACX Grants 2021 |